Acurx Pharmaceuticals, Inc. (ACXP)
3.88
-1.13
(-22.55%)
USD |
NASDAQ |
Mar 13, 16:00
3.90
+0.02
(+0.52%)
After-Hours: 20:00
Acurx Pharmaceuticals EPS Diluted (Quarterly) : -0.6722 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Adial Pharmaceuticals, Inc. | -1.797 |
| Quince Therapeutics, Inc. | -0.2492 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.578M |
| Total Expenses (Quarterly) | 1.578M |
| Enterprise Value | 2.325M |
| Earnings Yield | -100.3% |
| Normalized Earnings Yield | -100.32 |